Metastatic parotid gland malignancy: A preliminary study in an eastern Chinese population

J Stomatol Oral Maxillofac Surg. 2023 Apr;124(2):101309. doi: 10.1016/j.jormas.2022.10.008. Epub 2022 Oct 15.

Abstract

Objective: This study aimed to determine the incidence and clinicopathological patterns of metastatic carcinoma of the parotid gland.

Method: Ninety patients with parotid gland metastases admitted to our hospital between January 2003 and December 2018 were included in this study. Clinical and pathological data were obtained from the medical records and follow-ups. Kaplan-Meier analysis was used to assess overall survival of patients.

Results: Among the 90 patients, parotid gland metastases originated from the head and neck in 86 (95.6%), from non-head and neck in 4 (4.4%), from the oral cavity in 30(33.3%), and from the eyelid in 21 (23.3%). Among the 85 cases with parotid gland lymph node metastasis, 45 (52.9%) were diagnosed with extra-lymph node metastasis. The capsule of the parotid lymph nodes was thinner than that of the cervical lymph nodes (P < 0.05). Hematogenous metastases to the parotid gland (only five cases) were rare, mainly from the non-head and neck malignancies. Patients with oral squamous cell carcinoma and meibomian adenocarcinoma with parotid metastatic disease had poorer overall survival (P < 0.05).

Conclusion: Eastern China population analysis showed that parotid gland metastases usually arise from oral squamous cell carcinoma and eyelid, but rarely from cutaneous squamous cell carcinoma. Most cases metastasize to the parotid lymph nodes via the lymphatic system and are prone to extranodal extension with little or no facial nerve involvement. These findings have important implications for the treatment of metastatic parotid malignancies.

Keywords: Cancer; Gland malignancy; Parotid gland; Tumor metastasis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • East Asian People
  • Humans
  • Lymphatic Metastasis
  • Mouth Neoplasms* / pathology
  • Parotid Gland / pathology
  • Parotid Neoplasms* / epidemiology
  • Parotid Neoplasms* / secondary
  • Skin Neoplasms* / pathology
  • Squamous Cell Carcinoma of Head and Neck* / pathology